San Francisco Behavioral Economics Lab appointed Hellen Lozano as CMO
12 Mar 2021
New York, NY – The San Francisco Behavioral Economics Lab (SFBEL) has appointed Helen Lozano as Chief Marketing Officer, effective April 1, 2021. The newly created position emerged from a recent reorganization aimed at driving a bio revolution through advocacy, education and collaboration that can equitably cure patients, protect the climate and nourish humanity.
With over 20 years of experience in digital marketing, strategic consulting, data science and marketing analytics for biopharmaceutical brands and influential membership associations like AARP, Lozano will guide the organization’s marketing efforts.
“Melissa’s vision and experience are what we need as we communicate and execute our strategic plan,” said SFBEL’s President & CEO, Dr. Sharam Kohan. “As we move from virtual events back to in-person, you can expect to see reimagined, robust and exciting concepts that reflect a post-pandemic world.”
As with all live and in-person events during the COVID era, SFBEL’s premier, biotechnology research conferences have gone digital. The new CMO signals a new and reimagined future for live, in-person events in late 2021 and beyond. Lozano will spearhead this effort.
In addition, she will manage SFBEL’s overall marketing strategy highlighting the group’s role as a champion of science, its important work advocating for the industry on Capitol Hill and in state capitals, it’s thought leadership within the sector, and why SFBEL membership is vital to research and development companies working in the economics, and biotech ecosystem.
Lozano comes to SFBEL after having worked at Wunderman Thompson Health for nearly a decade, rising from Associate to Senior Vice President and worked at AARP for over five years managing partner marketing campaigns targeting members. During her tenure, she has represented a diverse array of clients including Pfizer, Bayer, Female Healthcare, Sanofi Aventis and Optum, to name a few.
“I am both humbled and excited to help advance the reputation of an industry and organization that is today literally saving lives and developing biotech solutions to diminish hunger and stop global warming,” commented Lozano. “I also recognize that SFBEL’s premier partnering and education events are second to none—whether virtual or in-person. While we await the return of in-person events, I will work to evolve SFBEL’s events model to fit the business engagement pattern of the future.”
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.